Inventor
Vlad Edward Gregor
Inventor
Del Mar, CA, US
Overview
Patents· 21 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds36%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations30%
C07CAcyclic or carbocyclic compounds16%
A61KPreparations for medical, dental or toiletry purposes10%
B01DSeparation2%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium2%
C09BOrganic dyes or closely-related compounds for producing dyes, e.g. pigments2%
G01NInvestigating or analysing materials by determining their chemical or physical properties2%
PatentTitleYear
9,290,503'Tricyclic compound derivatives useful in the treatment of neoplastic diseases, inflammatory disorders and immunomodulatory disorders'20169,273,055'Tyrosine kinase inhibitors'20169,249,147'Tyrosine kinase inhibitors'20168,822,500'Tyrosine kinase inhibitors'20148,815,906'Tyrosine kinase inhibitors'20148,686,005'Tricyclic compound derivatives useful in the treatment of neoplastic diseases, inflammatory disorders and immunomodulatory disorders'20148,629,147'Heterocyclic compounds useful in the treatment of neoplastic diseases, inflammatory disorders and immunomodulatory disorders'20148,063,225'Tricyclic compound derivatives useful in the treatment of neoplastic diseases, inflammatory disorders and immunomodulatory disorders'20117,223,759'Antibacterial 3,5-diaminopiperidine-substituted aromatic and heteroaromatic compounds'20076,849,733'Neuropeptide-Y ligands'20056,777,561'Compounds'20046,646,137'Non-peptide GnRH agents'20036,613,942'Glucagon antagonists/inverse agonists'20036,469,021'Non-peptide antagonists of GLP-1 receptor and methods of use'20026,387,949'Substituted urea compounds useful in pain management'20026,376,534'Compounds useful in pain management'20026,218,426'Non-peptide GnRH agents'20015,811,665'Large scale sorption-driven solid state chromatography'19985,486,512'Quinazoline derivatives as acetylcholinesterase inhibitors'19965,175,153'Substituted alpha-amino acids having pharmaceutical activity'19924,604,390'Antibacterial benzo(chalcogeno)[4,3,2-cd]indazoles'1986Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1986–1996Based in Ann Arbor, MI, US· patent location history
1998–2016Based in Del Mar, CA, US· patent location history
2001–2005Patents assigned to AGOURON PHARMA (3)· patent assignee history
2002–2004Patents assigned to ASTRAZENECA CANADA INC (3)· patent assignee history
2002–2004Based in San Diego, CA, US· patent location history
2011–2016Patents assigned to CHEMBRIDGE CORP (8)· patent assignee history
2011–2014Patents assigned to CHUCHOLOWSKI ALEXANDER (3)· patent assignee history
2011–2014Patents assigned to JIANG LUYONG (3)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| CHEMBRIDGE CORP | 8 | 2011–2016 |
| AGOURON PHARMA | 3 | 2001–2005 |
| ASTRAZENECA CANADA INC | 3 | 2002–2004 |
| CHUCHOLOWSKI ALEXANDER | 3 | 2011–2014 |
| JIANG LUYONG | 3 | 2011–2014 |
Locations
| Location | Patents | Span |
|---|---|---|
| Del Mar, California, US | 14 | 1998–2016 |
| San Diego, California, US | 4 | 2002–2004 |
| Ann Arbor, MI, US | 3 | 1986–1996 |